Compare Anza Therapeutics vs Nora Therapeutics
Customers evaluate the quality of Anza Therapeutics's products using the following success metrics.
Overview
Anza Therapeutics is based in United States
Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.
Nora Therapeutics is based in United States
Nora Therapeutics is a privately-held biotechnology company focused on developing therapeutics to address IVF failure and recurrent pregnancy loss, two reproductive conditions with significant unmet need. Nora's lead compound, NT100, is a novel biologic agent similar to a naturally occurring protein in the female reproductive tract and may better enable embryo implantation and pregnancy maintenance by optimizing maternal-fetal immune tolerance. For more information, please visit www.noratherapeutics.com.
Demo Video
Leadership
David Cook (President)
Jeffrey Tong (Chief Executive Officer, President)
Funding
Investors
Sofinnova Partners and Kleiner Perkins Caufield & Byers
Prospect Venture Partners, Vivo Capital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Anza Therapeutics has not claimed their profile.
Work for Anza Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Anza Therapeutics?
Claim your profile now.
Information not available because Nora Therapeutics has not claimed their profile.
Work for Nora Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Nora Therapeutics?
Claim your profile now.
News & Analysis
Anza Therapeutics has not been mentioned in our research.
Nora Therapeutics has been mentioned in our research 1 time.
Research Articles
